Seminars in Thoracic and Cardiovascular Surgery
Volume 21, Issue 2 , Pages 95-96 , Summer 2009

Multimodality Management of Malignant Pleural Mesothelioma: Introduction

References 

  1. Lanphear B, Buncher C. Latent period for malignant mesothelioma of occupational origin. J Occup Med. 1992;34:718–721
  2. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in northwestern Cape Providence. Br J Ind Med. 1960;17:260–271
  3. Selikoff IJ, Churg J, Hammond EC. Relation between exposure to asbestos and mesothelioma. N Engl J Med. 1965;272:560–565
  4. Price B, Ware A. Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. Am J Epidemiol. 2004;159:107–112
  5. Bianchi C, Bianchi T. Malignant mesothelioma: global incidence and relationship with asbestos. Ind Health. 2007;45:379–387
  6. Montanaro F, Rosato R, Gangemi M, et al. Survival of pleural malignant mesothelioma in Italy: a population-based study. Int J Cancer. 2009;124:201–207
  7. Hasegawa S, Tanaka F. Malignant mesothelioma: current status and perspective in Japan and the world. Gen Thorac Cardiovasc Surg. 2008;56:317–323
  8. OSHA. Safety and Health Topics: Asbestos. Washington, DC: Occupational Safety Health Administration; 2009;
  9. National Institute for Occupational Safety and Health. Work-related lung disease surveillance report 2007. Cincinnati, Ohio: US Department of Health and Human Services; 2008;
  10. Baldini EH, Recht A, Strauss GM, et al. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg. 1997;63:334–338
  11. Antman KH, Blum RH, Greenberger JS, et al. Multimodality therapy for malignant mesothelioma based on a study of natural history. Am J Med. 1980;68:356–362
  12. Sugarbaker DJ, Mentzer SJ, Strauss G. Extrapleural pneumonectomy in the treatment of malignant pleural mesothelioma. Ann Thorac Surg. 1992;54:941–946
  13. Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 1999;117:54–63, discussion, 63-65

PII: S1043-0679(09)00083-5

doi: 10.1053/j.semtcvs.2009.07.005

Seminars in Thoracic and Cardiovascular Surgery
Volume 21, Issue 2 , Pages 95-96 , Summer 2009

Article Tools